Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2026-05-22 @ 10:06 PM
Study NCT ID:
NCT02270632
Status:
TERMINATED
Last Update Posted:
2023-06-12
First Post:
2014-10-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX
Sponsor:
Philogen S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PH-F8IL10-03/13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None